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ABSTRACT

Danh, Tu M.S. Department of Biochemistry and Molecular Biology M.S. Program,
Wright State University, 2015. Analysis of chromatin accessibility of the human c-myc
replication origin.

The best characterized eukaryote replication model is of the budding yeast
Saccharomyces cerevisiae. Replication origins of S.cerevisiae are 100 to 200 bp in size
and contain an essential 11-bp autonomous replicating sequence (ARS) consensus
sequence (ACS). The origin recognition complex (ORC) binds to the ACS in order to
recruit additional replication factors (Cdt1, Cdc6, MCM, Cdc45) and together they form
the pre-replication complex (pre-RC).
Unlike budding yeast, the mammalian cells contain dispersed replication origins
in which multiple elements distributed over large distances act as replication start sites.
Mammalian DNA replication origins, such as the c-myc origin, contain a DNA
unwinding element (DUE), which is an AT-rich region that contains10-of-11 matches to
ARS consensus. Our lab primarily studies DNA replication of the human c-myc locus.
We have successfully integrated the wild-type 2.4 kb c-myc replication origin and its
various inactive mutants in a known ectopic chromosomal site in HeLa/406 cells in order
to study the multiple functional elements of this origin.
My thesis focused on investigating the minimal sequence required in mammalian
replication origin for replication activity. To address this question, I assessed the effects
of replication protein tethering on chromatin accessibility of inactivated c-myc origins
which are 930 bp or less and contain an intact DUE. In part I of my thesis, I describe how
I made two new HeLa/406 cell lines containing two different deletion mutants of the cmyc replicator core (which are 607 bp and 228 bp long) at the known ectopic
chromosomal site. In part II of my thesis, I describe how I created plasmids expressing
GAL4 DNA-binding domain (GAL4DBD)-BRG1 fusion proteins. BRG1 is a catalytic core
iv

subunit of SWI/SNF mammalian chromatin remodeling complex. Wild-type BRG1 and
catalytic inactive BRG1K798R mutant were used to make GAL4DBD fusion proteins.
In part III of my thesis, I evaluated the effects of GAL4DBD fusion proteins on
chromatin structure of the inactivated ectopic c-myc replicator via DNase I
hypersensitivity assay. The proteins used were Cdt1, a licensing protein necessary for
pre-RC formation; wild-type BRG1 and catalytically dead BRG1 mutant. GAL4DBD-Cdt1
has previously been shown to restore origin activity, as well as binding of replication
proteins such as ORC, MCM, Cdc45, and DUE-B. My data suggest that expression of
GAL4DBD-Cdt1 or of GAL4DBD-wild-type BRG1 can significantly increase the DNase I
sensitivity of the inactivated ectopic 5’ 930 bp c-myc origin, which contains both the
DUE and the GAL4 binding sites. However, the shorter c-myc replicators (607 bp or 228
bp) did not show any change in DNase I hypersensitivity when the same GAL4DBD-Cdt1
was expressed. These results indicate that in conjunction with GAL4DBD protein
tethering, the c-myc DUE alone is not sufficient for opening the chromatin structure of
the ectopic c-myc replicator. Thus, the reactivation of the ectopic c-myc replicator via
GAL4DBD protein tethering requires additional DNA elements besides the DUE.
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I. INTRODUCTION
DNA replication and DNA unwinding:
Chromosomes are the permanent archives of the information which directs cell
function. Thus, duplication of eukaryotic chromosomes is an essential part of the cell
cycle. This process is tightly regulated throughout the G1 and S phases, because any
errors (such as incompletion, inaccuracies, excessive DNA synthesis, etc.) can lead to
dysfunctions such as cell death, developmental defects, and cancer transformation.
Before beginning the process of DNA replication in S phase, the two DNA templates are
first unwound by DNA helicases (collectively known as the Cdc45-Mcm2-7-GINS or
CMG complex) and DNA polymerases are recruited to the same complex (Masai et al.,
2011).
The stepwise assembly of the initiation complex begins in G1 and continues to
early S phase (Figure 1). In G1 phase, chromatin structure of origin DNA is decondensed
in order to allow accessibility of helicases and other replication proteins. HBO1, which
form a complex with licensing factor Cdt1, is an acetyltransferase which causes histone
H4 acetylation, thus loosening nucleosomal packing (Miotto and Struhl, 2010). As a
result of chromatin modification, DNA helicase Mcm2-7 complex can be loaded onto
replication origins with the help of Cdt1, Cdc6, and origin-recognition complex (ORC,
which contains Orc1-Orc6 proteins) (Bell and Dutta, 2002). Together, they form the prereplication complex (pre-RC), which remains inactive until the early onset of S phase, in
which the cyclin-dependent kinase (CDK) level rises.
In S.cerevisiae, the Dbf4-dependent Cdc7 kinase (DDK) phosphorylates Mcm2-7
helicase so that Sld3 can be loaded onto the pre-RC. Cdk2 (CDK) phosphorylates the
replication factors Sld3 and Sld2. Subsequently, these phosphorylated factors can interact
with Dbp11 or Cut5 (S.cerevisiae or S.pombe orthologs of human TopBP1) to recruit
helicase activators Cdc45 and GINS to Mcm 2-7 complex (Zegerman and Diffley 2007).
Together, Cdc45, GINS and the double hexameric Mcm2-7 complex form the CMG
1

helicase. These replication factors (Sld2, Sld3, Dbp11/Cut5) dissociate after the CMG
assembly, which indicates that the involvement of said factors is likely to be minimal
after the completion of this process. DUE-B (DNA unwinding element binding protein)
has been shown to interact with Cdc45 at active replication origin. Additionally,
phosphorylation of DUE-B C-terminus regulates DUE-B interaction during DNA
replication initiation (Yan et al., 2014). In Xenopus egg extract, phosphorylated DUE-B
forms homodimers, whereas unphosphorylated DUE-B forms dimers as well as high
molecular weight complex (HMW) with Mcm2-7 helicases. During G1/S phase, Mcm2-7
is released from HMW by Cdc7 kinase activity from the HMW complex, and DUE-B is
phosphorylated. Conversely, DUE-B is unphosphorylated in M phase by protein
phosphatase PP2A and the HMW complex with Mcm2-7 is formed. These results are
consistent with previous studies which show that the equilibrium between Cdc7 and
PP2A activity is important for cell cycle transitions as well as DNA replication initiation
(Heller et al., 2011; Krasinka et al., 2011; and Chou et al., 2002).
Once the CMG complex is formed, Mcm2-7 helicase can unwind double stranded
DNA. RPA (Replication Protein A) is recruited to the origin to bind the single-strand
unwound DNA (ssDNA), polymerase α (Pol α) generate DNA primer to initiate DNA
synthesis on both strands (Burgers 2009). Finally, polymerases Ɛ and δ, responsible for
DNA replication of leading (pol Ɛ) and lagging (pol δ) strands, are recruited to the origin,
thereby initiating DNA synthesis (Larrea et al., 2010; Nick McElhinny et al., 2008; and
Pursell et al., 2007). These results, however, contradict with a recent genetic study of
S.cerevisiae, which showed that DNA pol δ plays a major role in replication of both
leading and lagging DNA strands (Johnson et al., 2015). In its entirety, the protein
complex (CMG, polymerases α, Ɛ, δ and RPA) formed after the recruitment of DNA
polymerases is called the replisome. Mcm10 is another important protein for DNA
replication initiation which has been shown to bind both dsDNA and ssDNA in vitro
(Fien et al., 2004). Mcm10 can interact with PCNA (a processivity factor of DNA
replication) and Pol α. Moreover, reduced pol α and pol δ loadings in the absence of
Mcm10 have been shown both in vitro (Heller et al., 2011) and in vivo (Kanke et al.,
2012). These data, taken together, suggest that Mcm10 acts as a scaffolding protein for
the replisome as the replication fork moves bidirectionally.
2

Figure 1. Stepwise Assembly of the CMG helicases before DNA replication initiation
in eukaryotic cells.
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Human c-myc replication origin:
The human-c-myc locus contains a chromosomal origin of bidirectional
replication (Figure 2). This origin has 2.4 kb c-myc core replicator, which comprises both
replicator elements and replication start sites. The c-myc core replicator is an
autonomously replicating fragment, which retains its replication activity after being
integrated into a different chromosomal location (Malott and Leffak, 1999; Liu et al.,
2003). Among the structural elements of the 2.4 kb c-myc origin core are the DNA
unwinding element (DUE), a series of positioned nucleosomes, several micrococcal
nuclease hypersensitive and DNase I hypersensitive sites, and several DNA segments that
are bent or in flexible conformations in vitro (Figure 2) (Liu et al., 2003). The DUE,
which contains three 10-of-11 matches to the S.cerevisiae ARS consensus, is A-T rich
and predicted to be unwound in vivo. Furthermore, it has been shown that DUE is
essential for replicator activity and is a target of DUE-B protein in vivo (Liu et al., 2003;
Casper et al., 2005; Kemp et al., 2007). Thus, the presence of these structures suggests
that the chromatin of c-myc origin core is in an open confirmation for DNA unwinding
and DNA replication.

4

Figure 2. Human c-myc locus (Chen, 2011)

5

Activation of human chromosomal replication origin via GAL4 protein tethering:
In order to model the effect of chromatin acetylation, replication protein binding,
and transcription on a specific replication origin, constructs of the c-myc core replicator
and its mutants have been successfully integrated by FLP recombinase at an ectopic
chromosomal site as a single copy. Using this system, the ectopic 2.4 kb c-myc replicator
was shown to have full bidirectional replication activity, nucleosomal positioning and
chromatin structures of the endogenous c-myc origin (Liu et al., 2003; Ghosh et al.,
2006). It has also been shown that the binding of replication proteins such as the ORC,
Mcm2-7, Cdc45 and DUE-B via chromatin immunoprecipitation (ChIP) is comparable to
that of the endogenous c-myc origin (Ghosh et al., 2006; Liu et al., 2012).
Furthermore, when the 3’ 1.4 kb c-myc DNA of the 2.4 kb c-myc replicator was
replaced by a cassette containing five tandem GAL4-binding sites (5xGAL4), the ectopic
c-myc replicator (also known as FRT.myc.5’(930)-GAL4) was inactivated. Because of
this 5xGAL4 replacement, several replication proteins (HBO1, Orc2, and Cdt1), along
with transcription factors E2F1 and CREB, can be targeted to the inactivated ectopic cmyc replicator by fusing the GAL4 DNA-binding domain (GAL4DBD) with these proteins
(Chen et al., 2013). As a result, the endogenous replication proteins such as Mcm2-7,
DUE-B, and Cdc45 were recruited to the inactivated c-myc origin, and origin activity
was fully restored to that of the 2.4 kb c-myc replicator. Consistently, the c-myc origin
DNA shows enhanced local chromatin acetylation in the presence of acetyltransferase
HBO1-GAL4DBD, which is suggestive of an open chromatin structure.

The catalytic core subunit BRG1/SMARCA4 of human SWI/SNF chromatin
remodeling complex:
Human SWI/SNF complex is a multi-subunit assembly, which regulates
transcription by altering chromatin structures. The complexes are composed of highly
conserved core subunits (green) and variant subunits (yellow) (Figure 3a). The
mammalian complexes have either BRM/SMARCA2 (Brahma) or BRG1/SMARCA4
(Brahma-related gene 1), which are mutually exclusive ATPase core subunits. The
stepwise process of chromatin remodeling is depicted in Figure 3b. In an inactive gene
region, chromatin is condensed and DNA is tightly wrapped around nucleosomes.
6

SWI/SNF can bind the chromatin and utilize the energy derived from ATP hydrolysis to
destabilize histone-DNA contact and form a free DNA loop. Once the DNA loop is
propagated, the complex can either slide to the nucleosome position or eject the adjacent
nucleosome. As a result, the DNA is free from the nucleosome, which leads to the
increased accessibility of DNA-binding factors to their targets (Côté et al., 1994).
To assess whether opening the chromatin structure of the inactivated
FRT.myc.5’(930)-GAL4 replicator plays a role in restored origin activity, we asked
whether the expression of either GAL4DBD-Cdt1 or GAL4DBD-BRG1 fusion proteins can
increase the DNase I hypersensitivity of this c-myc replicator. We also asked whether the
same GAL4DBD fusion proteins can affect the chromatin structure of two new shortened
c-myc replicators (607 bp and 228 bp), both of which have not only an intact DUE but
also GAL4 binding sites.

7

Figure 3: The composition and mechanism of SWI/SNF complexes (Wilson et al.,
2011)
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II. MATERIAL AND METHODS
Construction of plasmids:
Plasmids expressing GAL4DBD fusion proteins:
Plasmids pBABE BRG1, BRG1K798R were generous gifts from Dr. Ivana de la
Serna. Using In-Fusion HD cloning kit (Clontech), these cDNAs were cloned into a
linearized pEGFP GAL4DBD, which has the GAL4DBD in place of EGFP cDNA. The
genes of interest (BRG1, BRG1K798R) were amplified with PCR primers engineered with
15 bp extensions homologous to vector ends. After the sizes of PCR products were
verified on 1% agarose gel electrophoresis, the PCR products were purified using
E.Z.N.A cycle pure kit (Omega Biotek). The purified PCR products were incubated with
the linearized vector (via SalI and MfeI sites) in In-Fusion enzyme premix, for 15
minutes at 50oC. The cloning reaction was transformed into Stellar Competent cells
(Clontech), as recommended by the manufacturer’s instructions. The screened clones
were confirmed by restriction digests and DNA sequencing.
To select for BRG1 expression in blasticidin-treated HeLa cells, the blasticidin S
deaminase (BSD) cDNA was added to the plasmid containing the GAL4DBDBRG1/BRG1K798R cDNA. The pEGFP GAL4DBD-BRG1/BRG1K798R DNA constructs
were cloned into pZFN-BSD by replacing the zinc-finger nuclease (ZFN) cDNA. The
pZFN-BSD vector was linearized at NheI and PmeI sites. The GAL4DBDBRG1/BRG1K798R was digested by NheI and PsiI, with PsiI producing a blunt end and
NheI producing a sticky end. The ligation reaction was catalyzed by T4 DNA Ligase
(New England Biolabs), incubated at 16oC overnight, and transformed into E.coli DH5α
competent cells. The structure of plasmid containing GAL4DBD-BRG1-BSD was
confirmed via restriction digests and DNA sequencing.
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Plasmids for cell line construction:
Plasmid pFRT.myc contains the full length 2.4 kb c-myc replicator core. When
integrated in a known chromosomal location in HeLa/406 cells, this c-myc origin has
been shown to have full replication activity in vivo (Chen et al., 2013). On the contrary,
the plasmid pFRT.myc.5’(930)-GAL4 contains the inactivated c-myc replicator, which
has a 3’ 1420 bp DNA sequence replaced by five tandem GAL-4 binding sites
(5xGAL4). After diagnostic digestion with PstI, this plasmid DNA was used as a
template for inverse PCR, using three sets of phosphorylated primers, as depicted in
Figure 4 (primer F1-R1 set, primer F2-R2 set, primer F2-R1 set). The PCR products were
a linearized version of three new c-myc replicator mutants containing an intact DUE
sequence, and, respectively, 607, 625, and 228 bp of c-myc DNA. The PCR products
were purified and quantified using 1% agarose gel electrophoresis, followed by the
ligation reaction using T4 DNase ligase. The newly constructed deletion constructs were
verified via diagnostic digestion with PstI and DNA sequencing. The new plasmids were
named according to their length of c-myc DNA: pFRT.myc.5’(607)-GAL4,
pFRT.myc.5’(625)-GAL4, and pFRT.myc.5’(228)-GAL4.
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Figure 4. DNA maps of c-myc replicators used in this study.
The HindIII-XhoI fragment contains the wild-type 2.4 kb c-myc replicator core,
of which the 5’ and 3’ ends are shown in the map of pFRT.myc (A, ApaI; H, HindIII; S,
SpeI; Xh; XhoI). The in vivo DNA unwinding element (DUE) is indicated in red. The 3’
1420 bp of the c-myc core origin (indicated by the ∆ green box) was replaced by five
tandem GAL4 binding sites (grey) to construct pFRT.myc.5’(930)-GAL4. Blue primer
pair (forward F1 and reverse R1) and gold primer pair (forward F2 and reverse R2) are
phosphorylated inverse PCR primers. These primers hybridized in an outward direction,
and the PCR products had phosphorylated ends which can be ligated to produce circular
DNA constructs. Thus, the final constructs would be lacking the DNA sequences flanked
by their respective primer set (F1-R1, F2-R2, F2-R1), indicated by the green boxes (∆1,
∆2, and ∆1. The new constructs are mapped as pFRT.myc.5’(607)-GAL4,
pFRT.myc.5’(625)-GAL4 and pFRT.myc.5’(228)-GAL4.
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Western blotting and antibodies
Protein expression was determined in cell lysates by sodium dodecyl sulphatepolyacrylamide gel electrophoresis, followed by western blotting. M-PER mammalian
protein extraction reagent (Thermo Scientific) and proteinase inhibitor (20 µg/mL,
Sigma-Aldrich) were used as cell lysis buffer. After electrophoresis, proteins were
transferred to PVDF membrane (Immobilon-P transfer Millipore) by Genie Blotter (Idea
Scientific) for 60 minutes, at constant current, 0.90 mA. Anti-β-actin and anti-FLAG
antibodies were purchased from Sigma-Aldrich.

Cell line construction
Approximately 3.0 x 105 HeLa/406 cells, containing one FLP recombinase target
(FRT) site at a specific chromosomal location (Liu et al., 2003), were plated in individual
wells of a 24-well plate in Dulbelcco’s Modified Eagle Medium (4.5 g/L Glucose, LGlutamine) with 10% newborn calf serum and incubated in 5% CO2 at 37oC. Once the
wells were 90-95% confluent, 0.8 µg of pFRT.myc donor plasmid, 0.1 µg of FLP
recombinase expressing plasmid pOG44 and 2 µL of Lipofectamine 2000 were used for
transfection per well. 24 hours after transfection, the cells were trypsinized, transferred
from one well into one 15 cm diameter plate, in fresh media containing 600 µg/mL G418.
The cells were maintained by re-plating in this fashion every third day.
After 14 days of monitoring the cells, the cells were then maintained in media
containing 20 µM ganciclovir (GCV) for two days, followed by media containing 400
µg/mL G418 for three days, followed by media containing 20 µM GCV for two days. If
the cells had successful integration of the pFRT.myc donor plasmid, the HSV thymidine
kinase gene is interrupted, which subsequently renders the cells resistant to GCV
selection. After the GCV selection, the single surviving mother colonies were transferred
via cloning discs into individual wells of a 24-well plate of fresh media containing no
antibiotic. Once the cells became confluent, they were re-plated out on a 10 cm plate in
10 mL of media containing 20 µM GCV for two days, followed by media containing 400
µg/mL G418 for three days. This was the last drug selection before getting the cells ready
for PCR screening.
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The cells were collected at 95% confluence. Half of the cells were frozen in liquid
N2, and half was used for genomic DNA extraction. A total of 50 ng of genomic DNA
was used for PCR with HotStar Taq DNA polymerase (QIAGEN) and primer sets
specific for either the unoccupied construct (primers 1 and 2) or the occupied construct
after successful integration of the c-myc replicators (primers 1 and 3).

DNAse hypersensitivity assay
HeLa/406 derivative cell lines containing the c-myc replicator integrated at the
ectopic FRT site were cultured in DMEM with 10% newborn calf serum in 5% CO2 at
37oC. Approximately 1.0 x 106 cells in each well per 6-well plate were transfected with 8
µg of GFP-N1 control plasmid, or GAL4-fusion protein expression plasmids or no DNA.
A mixture of 10 µL Lipofectamine 2000 (Invitrogen) mixed with 250 µL Opti-MEM
reduced serum medium was used for each plasmid DNA transfection, as recommended
by the transfection manual. The GAL4-fusion plasmids used in this study are GAL4Cdt1, GAL4-BRG1 wild-type and K798R mutant. Cells were trypsinized and harvested
24 hours after GAL4-Cdt1 transfection. Cells were treated with 10 µg/mL blasticidin 24
hours after GAL-BRG1 transfection, followed by harvesting 24 hours after. All cell lines
used in this assay are: HeLa/FRT.myc.5’(930), HeLa/FRT.myc.5′(625)-GAL4,
HeLa/FRT.myc.5′(607)-GAL4 and HeLa/FRT.myc.5′(228)-GAL4.
The cells were spun down at 500 g for 1 minute, washed with ice-cold phosphate
buffered saline (PBS). The cell pellets were washed two more times, and then
resuspended in 500 µL of ice-cold 1x Lysis RSB/NP-40 buffer (10 mM HEPES, pH 7.2,
10 mM NaCl, 1.5 mM MgCl2, 0.5% Nonidet P-40), followed by incubation on ice for 10
minutes for complete lysis. The nuclei were sedimented at 1000 g for 2 minutes, and
washed with 500 µL RSB/NP-40 buffer. The nuclei were sedimented again at 1000 g for
2 min and resuspended in 1 mL of RSB/NP-40 buffer.
To approximate the concentration of nucleic acids in each sample, 10 µL of the
sample was diluted in 990 µL of 0.1% SDS, transferred into a glass cuvette, and exposed
to ultraviolet light at a wavelength of 260 nm. The optical density/absorbance at 260 nm
wavelength (A260) of each sample was measured by a spectrophotometer relative to a
SDS blank. The higher the sample concentration, the more ultraviolet light absorbed by
13

the sample. One A260 unit is known as the concentration of nucleic acids in 1 mL sample
to produce an absorbance of 1. One A260 unit of double-stranded DNA (dsDNA) equals
50 µg/mL concentration. The dsDNA concentration in µg/mL was determined by the
following equation: [dsDNA] = (A260) (50 µg/mL) (dilution factor (100)). In this study,
a total of 10 µg of sample DNA were used for each DNase I digestion experiment.
Each sample was digested with 10 units of RNAse-free DNase I (New England
Biolabs) (2 U/ml) in a total volume of 1 mL reaction after CaCl2 (0.5 mM final
concentration) was added. 200 µL of reaction mixture was aliquoted at zero time point
and the reaction was stopped with an equal volume of stop buffer (5% SDS, 10 mM
EDTA, pH 8.0). Four 200 µL aliquots were subsequently stopped in an identical manner
at the 5 minute, 10 minute, 20 minute, 30 minute, and 40 minute time points. 25 µL of
Proteinase K (400 µg/mL stock) and 4 µL RNAse A (10 mg/mL) were added to each
aliquot and the aliquots were incubated overnight at 55oC.
Total genomic DNA was extracted from control DNA transfected, plasmid
transfected and mock transfected HeLa/406 derivative cells with the E.Z.N.A Tissue
DNA kit, as recommended by the manual (Omega Bio-tek). The recovered DNA was
resuspended in 50 µL of ddH2O. 50 ng of genomic DNA was used as a template for each
PCR reaction containing Phire Hot Start II DNA Polymerase (Thermo Scientific) and 2
set of primers specific for either the ectopic mutant c-myc (pVU and pDUE) or the βglobin loci (pFor and pRev).
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III. RESULTS
Part I: Generation of stable HeLa/FRT.myc.5’ (930)-GAL4 mutant cell lines:
Cloning of deletion constructs of FRT.myc.5’ (930)-GAL4:
Previous studies suggested that while the deletion of DNA unwinding element
(DUE) DNA sequence does not eliminate the pre-replication complex (pre-RC)
formation, the DUE is essential for the activation of pre-RC (Ghosh et al., 2006; Chen et
al., 2013). Consequently, we are interested in determining the minimal DNA sequence
which is required for an active human replication origin. We developed three new
deletion mutants of c-myc replicator using the FRT.myc.5’(930)-GAL4 plasmid
containing the c-myc replicator, which has a 3’ 1420 bp DNA sequence replaced by five
tandem GAL-4 binding sites (5xGAL4) (Figure 4, 5a). This plasmid was subjected to
inverse PCR using three sets of phosphorylated primers, as depicted in Figure 4 (primer
F1-R1 set, primer F2-R2 set, primer F2-R1 set).
The PCR reactions yielded three new c-myc replicator mutants which contain an
intact DUE sequence, while lacking 320, 670, 300 bp fragments near the 5’end of c-myc
DNA as well as the 3’ 1420 bp fragment (Figure 4, 5a). The PCR products were purified
and quantified using 1% agarose gel electrophoresis, followed by the ligation reaction
using T4 DNAse ligase (Figure 5b). The newly circularized PCR products and the
original c-myc template (FRT.myc.5’(930)-GAL4) were digested with PstI and separated
on 1% agarose gel (Figure 5c). DNA sequencing confirmed the deletions in each
construct. The constructs are named based on the remaining length of c-myc DNA in
each plasmid, i.e., pFRT.myc.5’(607)-GAL4 has 607 bp of c-myc replicator core. They
are listed in the following order: construct (A) is FRT.myc.5’(607)-GAL4 which has
bases 381-704 deleted; construct (B) is FRT.myc.5’(625)-GAL4 which has bases 7491054 deleted; and construct (C) is FRT.myc.5’(228)-GAL4 which has bases 381-1052
deleted.
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Figure 5. Construction of truncated FRT.myc.5’ (930)-GAL4 plasmids.
(A) Plasmid maps of pFRT.myc.5’(930)-GAL4, pFRT.myc.5’(607)-GAL4,
pFRT.myc.5’(625)-GAL4, and pFRT.myc.5’(353)-GAL4. Black bars: PstI restriction
sites. Light green arrows: AmpR (ampicillin-resistant gene), NeoR/KanR
(neomycin/kanamycin resistant gene). Gold arrows: Ori (origin of replication). Grey
blocks: FRT (FLP-recombinase target site), 5xGAL4 (five tandem GAL4 binding sites),
SV40 poly(A) signal. Red block: DUE (DNA unwinding element). Blue green block: cmyc replicator cores with the indicated lengths.
(B) 1% agarose gel of purified PCR products which were circularized to create (607)
(pFRT.myc.5’(607)-GAL4), (228) (pFRT.myc.5’(228)-GAL4), and pFRT.myc.5’(625)GAL4) constructs.
(C) EtBr-stained 1% agarose gel of PstI digested plasmids of (930) (pFRT.myc.5’(930)GAL4) and three new deletion constructs. The expected sizes of digested fragments are
listed below the gel image.
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Making of HeLa/FRT.myc.5’ (930)-GAL4 mutant cell lines:
The targeted integration of FRT.myc.5’(607)-GAL4, FRT.myc.5’(228)-GAL4
was accomplished by FLP recombinase-mediated recombination between FRT sites in
the c-myc donor plasmid and the chromosomal FRT acceptor site (chromosome 18) in
HeLa/406, as previously done with the clonal cell lines containing the full length
FRT.myc (Liu et al., 2003) (Figure 6a) or the truncated FRT.myc.5’(930)-GAL4 (Ghosh
et al., 2004; Chen et al., 2013). Accurate integration of the new constructs was confirmed
by diagnostic PCR primers (mapped out as primers 1, 2, and 3 in the occupied acceptor
site, Figure 6a) that yielded products from either the empty or occupied acceptor sites.
Genomic DNA was isolated from one HeLa/406 empty acceptor cell line
(FRT.TK) and three HeLa/406 derivative cell lines containing different c-myc donor
plasmids, which are shown in the maps (Figure 6b) as FRT.myc.5’ (930)-GAL4,
FRT.myc.5’ (228)-GAL4, and FRT.myc.5’ (607)-GAL4. As expected, diagnostic primers
1 and 2 only amplified a PCR product with HeLa/406(FRT.TK) genomic DNA
containing the unoccupied acceptor site, but not with DNA from cells with the occupied
acceptor sites by any of the donor plasmids (Figure 6c). On the contrary, primers 1 and 3
amplified products only with DNA from cells with an occupied acceptor site (Figure 6c).
These results confirmed the stable integration of the new truncated versions of the c-myc
replicator into HeLa/406 acceptor site.
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Figure 6. Diagnostic PCR screening of newly constructed ectopic c-myc cell lines.
(A) FLP recombinase-mediated DNA integration into a HeLa ectopic chromosomal site.
HeLa/406 cells contain a single chromosomal copy of the plasmid pHyg.FRT.TK, which
is known as the unoccupied chromosomal acceptor site. Hyg, hygromycin resistance
gene; FRT, FLP recombinase target site; TK, herpes simplex virus thymidine kinase
gene. The Hyg-FRT-TK fusion protein renders cells resistant to hygromycin and sensitive
to ganciclovir. pFRT.myc (shown linearized) contains the 2.4-kb HindIII/XhoI fragment
of the c-myc origin or its derivatives. Neo, G418 resistance gene with promoter replaced
by FRT. pOG44 is an FLP recombinase expression plasmid, cotransfected with
pFRT.myc. Accurately targeted cells are resistant to hygromycin, G418, and ganciclovir.
PCR primers 1, 2, and 3 (horizontal arrowheads) give products diagnostic for the
unoccupied acceptor site (primers 1 and 2) or the occupied acceptor site (primers 1 and
3). Sequence-tagged sites Hyg, pVU, pML, and TK used in Q-PCR quantitation are also
indicated (Liu et al., 2003).
(B) Maps of the DNA sequences of the occupied sites in HeLa/406 derivative cell lines.
Flanked upstream and downstream by the FRT sites, each donor plasmid contains
neomycin gene and one of the three truncated versions (5’ 930 bp, 5’ 228 bp, and 5’ 607
bp) of the c-myc replicator (including the DUE) (solid black box) attached to GAL4binding sites. The bold print indicates the new deletion mutants of c-myc replicator.
(C) Genomic DNA from 406-derived cell lines was isolated and amplified by PCR with
primer pairs 1 and 2 or 1 and 3. DNA from HeLa/406 empty acceptor cells is shown as
FRT.TK. DNA from clonal cell lines HeLa/FRT.myc.5’(930)-GAL4,
HeLa/FRT.myc.5’(228)-GAL4, or HeLa/FRT.myc.5’(930)-GAL4 is shown.
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In this study, all clonal cell lines are named for their respective donor plasmids, as
listed in Figure 7a. Therefore, at the ectopic chromosomal FRT site, HeLa/FRT.myc cells
contain the wild-type 2.4 kb core c-myc replicator; HeLa/FRT.myc. 5’(228)-GAL4 cells
contain 5’ 228 bp of the c-myc replicator (including the c-myc DUE) flanked by
5xGAL4-binding site cassette; HeLa/FRT.myc.5’(930) cells contain 5’ 930 bp of the cmyc replicator without 5xGAL4-binding site cassette; HeLa/FRT.myc. 5’(930)-GAL4
cells contain 5’ 930 bp of the c-myc replicator flanked by 5xGAL4-binding site cassette;
HeLa/FRT.GAL4 cells contain the 5xGAL4-binding site cassette; HeLa/FRT.myc.
5’(607)-GAL4 cells contain 5’ 607 bp of the c-myc replicator flanked by 5xGAL4binding site cassette. The sizes of ectopic mutant c-myc replicators in these HeLa/406
derivative cells were determined using PCR primers (pVU and pVD) flanking of the cmyc origin, as shown in the FRT.myc in Figure 7a. The PCR results, shown Figure 7b,
confirmed that all of HeLa/406 derivative cell lines have the correct donor plasmids.
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Figure 7. Size confirmation of the ectopic sites in all HeLa/406 derivative cell lines.
(A) Maps of the ectopic sites in all HeLa/406-derived cell lines. The cell lines are named
for their respective pFRT integrants. pVU and pVD are PCR primers flanking the c-myc
replicators, as indicated by the small black square.
(B) Genomic DNA from 406-derived cell lines was isolated and amplified by PCR with
primer pair pVU and pVD. The expected sizes for the PCR products are listed below the
gel image in accordance to their respective lanes on the gel.
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Part II: Expression of GAL4DBD fusion proteins:
Cloning and expression of GAL4DBD-wild-type BRG1 and BRG1 K798R mutant:
Plasmids pEGFP GAL4DBD- wild-type BRG1 and BRG1 K798R mutant were
digested with PsiI and NheI (Figure 8a) in order to extract the cDNAs of GAL4DBD fused
with wild-type BRG1 or BRG1 K798R mutant. The vector pZFN-BSD (blasticidin S
deaminase) contained the zinc finger (ZFN) cDNA, which was removed by NheI and
PmeI, generating compatible ends as the inserts (GAL4-wild-type BRG1 or BRG1 K798R
mutant) (Figure 8b). Both the linearized pZFN-BSD vector and the insert fragments of
GAL4DBD-wild-type BRG1 and BRG1 K798R mutant were gel extracted from 1% agarose
gel before purification by E.Z.N.A Gel Extraction kit. The ligated products GAL4DBDwild-type BRG1-BSD and GAL4DBD-BRG1 K798R -BSD were confirmed after two
diagnostic restriction digests, the first one with BamHI, and the second one with SacII
and SpeI. The sizes of digested fragments were predicted via Snapgene construct map of
GAL4DBD-BRG1-BSD.
The correct GAL4DBD-wild-type BRG1-BSD and GAL4DBD-BRG1 K798R-BSD
plasmids with appropriately cut DNA fragments were shown in Figure 9b. The sequences
of these plasmids were further verified by DNA sequencing. Consequently, the plasmids
expressing GAL4DBD fusions with wild-type BRG1 or the catalytically inactive BRG1
K798R

mutant were transiently transfected in HeLa cells for 24 hours, followed by 24 hours

of blasticidin treatment. Because these plasmids contain the blasticidin S deaminase gene,
which codes for the blasticidin-degrading enzyme, the positively-transfected cells are
rendered blasticidin resistant. As shown in Figure 9c, GAL4DBD-wild-type BRG1 treated
cells show modest expression while GAL4DBD-BRG1 K798R mutant shows twice as much
expression (the asterisk indicates the GAL4-specific band; beta-actin was used as the
loading control). The vector pZFN-BSD treated cells, as expected, show no expression of
GAL4DBD-BRG1 against anti-GAL4DBD antibody.
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Figure 8. Cloning of GAL4DBD-wild-type BRG1-BSD and GAL4DBD-BRG1 K798RBSD.
(A) Vector preparation. Left: Plasmid map of vector pZFN-BSD (blasticidin S
deaminase). The light purple region indicated the cDNA of zinc-finger nuclease (ZFN)
which would be replaced by the cDNA of GAL4DBD-wild-type BRG1. The restriction
sites PmeI and NheI (red) were used to linearize the vector. Right: The vector pZFN-BSD
was digested by PmeI and NheI restriction enzymes in order to remove the ZFN cDNA.
The right fragment (4956 bp) was gel extracted and purified before ligation. (M) indicates
Gene Ruler 1 kb plus DNA ladder (Thermo Scientific). The expected sizes of vector
fragments are shown below the gel image.
(B) Insert preparation. Left: Plasmid map of insert pEGFP GAL4DBD-wild-type BRG1.
Since the -BRG1 K798R mutant is caused by a missense point mutation, the length of the
DNA sequenced and the protein molecular weight are unchanged. The purple region
indicated the cDNA of GAL4DBD-wild-type BRG1, which will be used as the insert
during ligation. The restriction sites NheI and PsiI (red) were used to extract the insert.
Right: The inserts pEGFP GAL4DBD-wild-type BRG1 or pEGFP GAL4DBD-BRG1K798R
mutant were digested with NheI and PsiI, and separated by agarose gel electrophoresis.
The right fragment (5373 bp) was gel extracted and purified before ligation. WT indicates
wild-type BRG1 and MT indicates BRG1K798R mutant. The expected sizes of digested
pEGFP GAL4DBD-wild-type BRG1 after NheI and PsiI digestion are shown.
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Figure 9. Confirmation of GAL4DBD-wild-type BRG1-BSD and GAL4DBD-BRG1
K798R-BSD.

(A) Plasmid map of plasmid GAL4DBD-wild-type BRG1-BSD. GAL4DBD-wild-type
BRG1 and BSD cDNAs are in purple and green, respectively. CMVp in white denotes
the DNA sequences of CMV promoter and enhancer. SV40p in white denotes the DNA
sequences of SV40 promoter and SV40 origin of replication. BamHI, SacII, and SpeI
restriction sites are in red.
(B) The correct plasmid DNAs of GAL4DBD-wild-type BRG1-BSD and GAL4DBD-BRG1
K798R

-BSD of were linearized by BamHI or digested by SacII and SpeI. (M) indicates

Gene Ruler 1 kb DNA ladder (Thermo Scientific). (B) indicates BamHI-linearized
plasmid DNA, (S/S) indicates SacII and SpeI DNA fragments. The expected sizes of
DNA fragments are shown.
(C) Western blot with anti-GAL4 antibody of extracts from HeLa cells transfected with
vector only (lane 1), cells expressing GAL4DBD-wild-type BRG1 (lane 2), and cells
expressing GAL4DBD-BRG1K798R mutant (lane 3). The asterisk indicates the GAL4DBD
fusion protein of wild-type and mutant form of BRG1. Beta-actin protein expression was
used as a loading control.
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Part III: Chromatin structures of the ectopic mutant c-myc replicators in HeLa cells:
Previous study (Chen et al., 2013) has shown that several replication proteins
(HBO1, Cdt1, Orc2) can be recruited to the inactivated 5’ 930 bp c-myc replicator using
GAL4 protein- GAL4 DNA attachment, leading to the reactivation of the truncated
replicator and the recruitment of other endogenous replication proteins (Mcm2-7, ORC,
Cdc45, and DUE-B). In this study, the chromatin structure of the inactivated 5’ 930 bp cmyc replicator in the presence of GAL4DBD fusion protein (Cdt1 and BRG1) tethering
was further elucidated using DNase I hypersensitivity assay. Cdt1 is a good candidate
protein because it has been shown to restore origin activity when being fused with
GAL4DBD protein. BRG1 (SMARCA4) is the catalytic component of the human
SWI/SNF chromatin remodeling complex. Wild-type BRG1 has been shown to use
ATPase activity to disrupt histone-DNA contacts, leading to the repositioning of the
nucleosome and exposure of naked DNA for transcription (Wilson and Roberts, 2011).
Thus, we hypothesize that this protein, once fused with GAL4DBD protein, increases the
nuclease sensitivity of inactivated FRT.myc.5’(930)-GAL4 origin.
DNase I digestion and nuclease sensitivity of HeLa/FRT.myc.5’(930)-GAL4 cells:
Before DNase I hypersensitivity assay (previously described in Methods section,
Figure 10) was performed on GAL4DBD fusion protein-transfected HeLa cells, DNAse
digestion and PCR across the ectopic c-myc and beta-globin loci were used to evaluate
chromatin structures of non-transfected HeLa/FRT.myc.5’(930)-GAL4 cells. Timedependent DNase-digested HeLa/FRT.myc.5’(930)-GAL4 genomic DNA samples from
two separate experiments were visualized on EtBr-stained 1% agarose gel, as shown in
Figure 11b. The DNA smears were formed due to a series of fragmented DNA in various
sizes. The longer the nuclei were treated with DNase I, the longer the smears appear on
the gel, which indicated that nucleosomal DNA were being digested by DNase I in a
time-dependent manner.
The same genomic DNA samples extracted from DNase-digested
HeLa/FRT.myc.5’(930)-GAL4 nuclei were amplified simultaneously by PCR primers
(primers pVU, pDUE, pFor, pRev) that yielded products from both the ectopic c-myc and
β-globin loci. As seen in Figure 11c, primers pVU and pDUE amplified a PCR product
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1157 bp while β-globin primers pFor and pRev amplified a 668 bp PCR product. The
intensity of β-globin product remains unchanged across time points, which indicates that
β-globin chromatin is in a closed confirmation and inaccessible to DNaseI. This data is
consistent with previous study that showed modest β-globin origin activity, indicated by
the low nascent-strand abundance of several initiation sites within the 40 kb region of the
β-globin gene locus (Kamath and Leffak, 2001). Therefore, β-globin locus was used as an
internal normalizer for DNase I sensitivity.
Subsequently, the DNase I sensitivity of the ectopic c-myc replicator was
determined by the ratio of the band intensity of PCR product specific for the β-globin
locus over that of the ectopic c-myc locus (Ratio = β-globin/ectopic). Thus, the higher
this ratio, the greater the sensitivity of the ectopic site relative to the β-globin locus. Nontransfected HeLa/FRT.myc.5’(930)-GAL4 cells were shown to have a slight nuclease
sensitivity at the ectopic c-myc locus, indicated by a decreasing trend in band intensity of
ectopic PCR products at later time points (20, 30, and 40 minutes) (Figure 11c). This
result can be explained by the various DNA structures within the 5’ 930 bp of the c-myc
replicator, such as the easily unwound AT rich DUE sequence. However, the 5’ 930 bp of
the c-myc replicator has been shown to remain inactive in the absence of GAL4DBD
fusion protein tethering (Chen et al., 2013). Thus, the c-myc core replicator is a nucleaseaccessible (‘open’) chromatin structure.
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Figure 10. Schematic experimental design of DNase I hypersensitivity assay.
The HeLa/406-derived cells were transiently transfected with GAL4DBD fusion proteins
of interest (Cdt1, wild-type BRG1 or BRG1 K798R mutant) for 24 hours to 48 hours. The
cells were harvested, followed by lysis using RSB/NP-40 buffer and resuspension of
isolated nuclei. Subsequently, the nuclear DNA was digested by DNase I in a timedependent manner. After the digestion, the genomic DNA was extracted, purified, and
amplified simultaneously via PCR using primer sets specific for the ectopic c-myc (pVU
and pDUE) and β-globin (pFor, pRev) loci.
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Figure 11. Nuclease sensitivity of non-transfected HeLa/FRT.myc.5’(930)-GAL4
cells. (A) Map of the ectopic c-myc locus in HeLa/FRT.myc.5’(930)-GAL4 cells. The
solid box shows the 5’ 930 bp of the inactivated c-myc replicator. The small black
squares show the positions of pVU and pDUE primers on the c-myc replicator.
(B) Genomic DNAs of time-dependent DNase I-treated non-transfected
HeLa/FRT.myc.5’(930)-GAL4 cells were extracted and purified, followed by
visualization via agarose gel electrophoresis. The two agarose gel images were results
from two separate digestions.
(C) The same genomic DNAs were used as templates for PCR with primers which
amplified across both the ectopic c-myc and β-globin loci. The PCR products were
visualized on 1% agarose gel and labelled according to the locus from which they were
amplified.
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Expression of GAL4DBD-Cdt1 increases the nuclease sensitivity only in
HeLa/FRT.myc.5’(930)-GAL4 cells, and not HeLa/FRT.myc.5’(930) cells:
GAL4DBD-Cdt1 or GFP proteins were expressed in the FRT cell lines and
visualized by anti-Cdt1 antibody (Figure 12a). In comparison to GFP-transfected
samples, expression of GAL4DBD-Cdt1 induced a two-fold increase in nuclease sensitivity
of the ectopic c-myc origin in HeLa/FRT.myc.5’(930)-GAL4 cells (Figure 12b). The
DNase I hypersensitivity of non-transfected, GFP-N1 vector-transfected, GAL4DBD-Cdt1transfected HeLa/FRT.myc.5’(930)-GAL4 cells were quantified using linear regression
of the band intensity ratios of ectopic c-myc PCR product over β-globin PCR product (βglobin/ectopic ratio) (Figure 12c). Each treatment was done in triplicate; the slope of each
linear regression indicated the increasing rate of β-globin/ectopic ratios; and the Y
intercept was set at one for all linear regression trend lines.
In contrast, expression of GAL4DBD-Cdt1 did not induce an increase in nuclease
sensitivity of the ectopic c-myc origin in HeLa/FRT.myc.5’(930) cells which do not
contain a GAL4 binding site (Figure 13b). The β-globin/ectopic intensity ratios were
approximately one across time points in both mock and GAL4DBD-Cdt1-transfected
samples, as shown in the scatter plot (Figure 13c). These results were consistent with
previous study which showed that expression of GAL4DBD-Cdt1 to the inactivated
FRT.myc.5’(930)-GAL4 replicator restored origin activity, due to the tethering between
GAL4DBD fused protein and GAL4 DNA sequence. However, without a GAL4 binding
site, no tethering was achieved with the inactivated FRT.myc.5’(930) replicator, which
led to no restored origin activity. These results also confirmed the hypothesis that the
chromatin structure of the FRT.myc.5’(930)-GAL4 becomes more accessible to nuclease
in the presence of replication proteins (Cdt1 in this experiment) at the ectopic c-myc
replicator.
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Figure 12. GAL4DBD-Cdt1 fusion protein increased the nuclease sensitivity of the
ectopic c-myc origin in HeLa/FRT.myc.5’(930)-GAL4 cells.
(A) Western blot with anti-Cdt1 antibody of extracts from HeLa/FRT.myc.5’(930)-GAL4
cells expressing GAL4DBD-Cdt1 (left lane), and cells transfected with vector only (right
lane). The arrows represent protein bands of endogenous Cdt1 and GAL4DBD-Cdt1.
(B) Genomic DNAs of time-dependent DNase I-treated of GFP-N1 vector-transfected,
and GAL4DBD-Cdt1-transfected HeLa/FRT.myc.5’(930)-GAL4 cells were extracted and
purified before PCR amplification. The PCR products specific to the ectopic c-myc locus
(1157 bp) or β-globin locus (668 bp) were visualized on agarose DNA gel.
(C) The ratios of band intensities of ectopic c-myc PCR product over β-globin product
(β-globin/ectopic ratios) from non-transfected, vector-transfected, and GAL4DBD-Cdt1transfected HeLa/FRT.myc.5’(930)-GAL4 cells were scatter-plotted and fitted for linear
regressions. Each treatment was repeated three times, and the DNase I hypersensitivity of
each treatment is quantified by the slope of each linear regression. Red squares indicate
GFP-N1 vector-transfected DNA samples, and blue diamonds indicate GAL4DBD-Cdt1transfected DNA samples, and green triangles indicate non-transfected DNA samples.
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Figure 13. GAL4DBD-Cdt1 fusion protein did not change the nuclease sensitivity of
the c-ectopic c-myc origin in HeLa/FRT.myc.5’(930) cells.
(A) Map of the ectopic c-myc locus in HeLa/FRT.myc.5’(930) cells.
(B) Genomic DNAs of time-dependent DNase I -treated of GFP-N1 vector-transfected,
and GAL4DBD-Cdt1-transfected HeLa/FRT.myc.5’(930) cells were extracted and purified
before PCR amplification. The PCR products specific to the ectopic c-myc (1157 bp) or
β-globin locus (668 bp) were visualized on agarose DNA gel.
(C) The β-globin/ectopic ratios of vector-transfected, and GAL4DBD-Cdt1-transfected
HeLa/FRT.myc.5’(930) cells were plotted. Red squares indicate GFP-N1 vectortransfected DNA samples, and blue diamonds indicate GAL4DBD-Cdt1-transfected DNA
samples.
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Expression of GAL4DBD-Cdt1 did not increase the nuclease sensitivity in
HeLa/FRT.myc.5’(607)-GAL4 cells, or HeLa/FRT.myc.5’(228)-GAL4 cells:
As previously mentioned, two more HeLa/FRT cell lines were created with 5’ 607
bp and 5’ 228 bp c-myc replicators flanked by 5xGAL4 sequence. We were interested in
the nuclease sensitivity of these cell lines because while they retained the DUE sequence,
they had additional deletions of 320 bp or 600 bp upstream of the DUE. The
HeLa/FRT.myc.5’(607)-GAL4 and HeLa/FRT.myc.5’(228)-GAL4 cells were transfected
with GAL4DBD-Cdt1 and digested in the same procedure as that of
HeLa/FRT.myc.5’(930)-GAL4 cells. GAL4DBD-Cdt1 expression in these cell lines was
visualized by anti-Cdt1 in conjunction with endogenous Cdt1 (Figures 14a, 15a). The
GAL4DBD-Cdt1 protein expression in HeLa/FRT.myc.5’(930)-GAL4 was comparable to
that in HeLa/FRT.myc.5’(607)-GAL4, and approximately four times more than that in
HeLa/FRT.myc.5’(607)-GAL4 (Figures 12a, 14a, 15a). However, because GAL4DBDCdt1 was in great excess over GAL4 binding sites, we expected that lower concentration
of GAL4DBD-Cdt1 does not affect the occupancy of GAL4DBD-Cdt1 at the ectopic sites.
In comparison to mock GFP-transfected samples, GAL4DBD-Cdt1-transfected
samples had no significant change in nuclease sensitivity in both FRT.myc.5’(607)GAL4 and FRT.myc.5’(228)-GAL4 replicators (Figures 14c, 15c). Furthermore, the
scatter plots for both HeLa/FRT.myc.5’(607)-GAL4 and HeLa/FRT.myc.5’(228)-GAL4
also confirmed that the β-globin/ectopic ratios were not different between GFPtransfected GAL4DBD-Cdt1-transfected samples (Figures 14d, 15d).
These results indicated that the chromosomal DNA of the ectopic mutant c-myc
replicators (FRT.myc.5’(607)-GAL4 and FRT.myc.5’(228)-GAL4) remained in a
condensed state and hence became inaccessible to DNase I nuclease. Consequently, these
results suggest that GAL4DBD-Cdt1 tethering to the c-myc DUE sequence might not be
sufficient, and that additional DNA sequences are required in conjunction with the DUE
to unwind the origin DNA necessary for the restored origin activity of these truncated cmyc replicators.
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Figure 14. GAL4DBD-Cdt1 fusion protein did not change the nuclease sensitivity of
HeLa/FRT.myc.5’(607)-GAL4 cells.
(A) Western blot with anti-Cdt1 antibody of extracts from HeLa/FRT.myc.5’(607)-GAL4
cells expressing GAL4DBD-Cdt1 (left lane), and cells transfected with vector only (right
lane). The arrows represent protein bands of endogenous Cdt1 and GAL4DBD-Cdt1.
(B) Map of the ectopic c-myc locus in HeLa/FRT.myc.5’(607)-GAL4 cells.
(C) Genomic DNAs of time-dependent DNase I-treated of GFP-N1 vector-transfected,
and GAL4DBD-Cdt1-transfected HeLa/FRT.myc.5’(607)-GAL4 cells were extracted and
purified before PCR amplification. The PCR products specific to the ectopic c-myc locus
(834 bp) or β-globin locus (668 bp) were visualized on agarose DNA gel.
(D) The β-globin/ectopic ratios of vector-transfected, and GAL4DBD-Cdt1-transfected
HeLa/FRT.myc.5’(607)-GAL4 cells were plotted. Red squares indicate GFP-N1 vectortransfected DNA samples, and blue diamonds indicate GAL4DBD-Cdt1-transfected DNA
samples.
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Figure 15. GAL4DBD-Cdt1 fusion protein did not change the nuclease sensitivity of
HeLa/FRT.myc.5’(228)-GAL4 cells.
(A) Western blot with anti-Cdt1 antibody of extracts from HeLa/FRT.myc.5’(228)-GAL4
cells expressing GAL4DBD-Cdt1 (left lane), and cells transfected with vector only (right
lane). The arrows represent protein bands of endogenous Cdt1 and GAL4DBD-Cdt1.
(B) Map of the ectopic c-myc locus in HeLa/FRT.myc.5’(228)-GAL4 cells.
(C) Genomic DNAs of time-dependent DNase I-treated of GFP-N1 vector-transfected,
and GAL4DBD-Cdt1-transfected HeLa/FRT.myc.5’(228)-GAL4 cells were extracted and
purified before PCR amplification. The PCR products of specific to the ectopic c-myc
locus (455 bp) or β-globin locus (668 bp) were visualized on agarose DNA gel. (C) The
β-globin/ectopic ratios of vector-transfected, and GAL4DBD-Cdt1-transfected
HeLa/FRT.myc.5’(228)-GAL4 cells were plotted. Red squares indicate GFP-N1 vectortransfected DNA samples, and blue diamonds indicate GAL4DBD-Cdt1-transfected DNA
samples.
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Expression of GAL4DBD-wild-type BRG1 or BRG1 K798R fusion proteins increases
the nuclease sensitivity in HeLa/FRT.myc.5’(930)-GAL4 cells:
GAL4DBD-wild-type BRG1, GAL4DBD-BRG1 K798R mutant, and pZFN-BSD
vector were expressed in HeLa/FRT.myc.5’(930)-GAL4 cells and visualized by antiGAL4 antibody (Figure 17a). After normalization by beta-actin loading control, the
expression of GAL4DBD-BRG1K798R was shown to be two times stronger than that of
GAL4DBD-wild-type BRG1. This result was consistent with previous expression profile of
GAL4DBD-wild-type BRG1, GAL4DBD-BRG1 K798R mutant (Figure 9c).
In order to confirm that the DNase I was the only nuclease affecting the
sensitivity of HeLa/FRT nucleosomal DNA, the nuclei samples from vector-transfected
cells were treated identically with or without DNase I addition. As a result, the nontreated nuclei showed no nuclease sensitivity at both ectopic c-myc and β-globin loci, up
to 40 minutes (Figure 16a), whereas the DNase I-treated nuclei showed moderate
sensitivity at the ectopic c-myc locus (Figure 16b). This experiment confirmed that
endogenous nucleases did not interfere with the DNase I hypersensitivity assay and
DNase I was the main enzyme digesting nucleosomal DNA in these HeLa/FRT cell lines.
Subsequently, PCR products of HeLa/FRT.myc.5’(930)-GAL4 expressing either
GAL4DBD-wild-type BRG1 or BRG1K798R mutant were visualized on 1% agarose gel
(Figure 17b). In comparison to empty vector-transfected samples (Figure 16b), GAL4DBD
wild-type BRG1-transfected samples (both wild-type and mutant forms) had increased
nuclease sensitivities at the ectopic c-myc locus, indicated by a faster decreasing trend in
band intensities of ectopic PCR products. Furthermore, the scatter plot of each treatment
(Figure 17c) confirmed the increased DNase I sensitivity of FRT.myc.5’(930)-GAL4
replicator when expressed GAL4DBD- wild-type BRG1 or BRG1K798R mutant. Using the
slope of each linear regression to approximate the increasing rate of the β-globin/ectopic
ratio, the DNase I sensitivity of wild-type BRG1-transfected and BRG1K798R mutanttransfected samples was respectively 3.6 times and 2.6 times higher than that of vectortransfected samples.
These results supported the hypothesis that GAL4DBD- wild-type BRG1 fusion
protein might be able to modify chromatin structure of the inactivated FRT.myc.5’(930)GAL4 replicator, leading to increased nuclease sensitivity. The catalytic-dead BRG1K798R
44

mutant, while it still sensitized the ectopic c-myc origin to DNase I, decreased the DNase
I sensitivity of HeLa/FRT.myc.5’(930)-GAL4 by 27%. As shown in Figure 17a, the
expression profile of GAL4DBD- wild-type BRG1 in the cells was only half of that
GAL4DBD- BRG1K798R mutant. Thus, if GAL4DBD- wild-type BRG1 was expressed to the
same level as that of GAL4DBD- BRG1K798R, the fusion protein might have further
sensitized the inactivated c-myc origin.
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Figure 16. Endogenous nucleases did not interfere with DNase I hypersensitivity
assay. (A) Genomic DNAs of time-dependent non-treated vector-transfected
HeLa/FRT.myc.5’(930)-GAL4 cells were extracted and purified before PCR
amplification. The PCR products specific to the ectopic c-myc locus (1157 bp) or βglobin locus (668 bp) were visualized on agarose DNA gel.
(B) Genomic DNAs of time-dependent DNase I-treated vector-transfected
HeLa/FRT.myc.5’(930)-GAL4 cells were extracted and purified before PCR
amplification. The PCR products were visualized on agarose DNA gel.
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Figure 17. GAL4DBD-BRG1 (both wild type and mutant forms) fusion protein
increased the nuclease sensitivity of HeLa/FRT.myc.5’(930)-GAL4 cells.
(A) Western blot with anti-GAL4 antibody of extracts from HeLa/FRT.myc.5’(930)GAL4 cells transfected with vector only (lane 1), cells expressing GAL4DBD-wild-type
BRG1 (lane 2), cells expressing GAL4DBD-BRG1K798R mutant (lane 3).
(B) Genomic DNAs of time-dependent DNase I-treated of GAL4DBD-BRG1K798R mutanttransfected, or GAL4DBD- wild-type BRG1-transfected, HeLa/FRT.myc.5’(930)-GAL4
cells were extracted and purified before PCR amplification and agarose gel
electrophoresis.
(C) The β-globin/ectopic ratios of vector-transfected, GAL4DBD- wild-type BRG1transfected, and GAL4DBD-BRG1K798R mutant-transfected HeLa/FRT.myc.5’(930)-GAL4
cells were scatter-plotted and fitted for linear regressions. GAL4DBD- wild-type BRG1- or
GAL4DBD-BRG1K798R mutant transfection was done once, and vector transfection was
done two times, and the DNase I hypersensitivity of each treatment is quantified by the
slope of each linear regression. Red squares indicate GAL4DBD- wild-type BRG1
transfected DNA samples, blue diamonds indicate GAL4DBD-BRG1K798R transfected
DNA samples, and green triangles indicate vector-transfected DNA samples.
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IV. DISCUSSION
DNA unwinding element (DUE) is not sufficient to reactivate an inactive replicator:
DUEs have been found in DNA replication origins from prokaryotes to
eukaryotes (Benbow et al., 1992; Dobbs et al., 1994; Huang and Kowalski, 1996; Ishimi
and Matsumoto, 1994; Liu et al., 2003). In yeast, it has been shown that the binding site
for origin recognition complex (ORC) and the easily unwound sequence DUE are two
essential components for DNA replication initiation, regardless of the different
replication origins.
Our studies have consistently shown that DUEs are essential elements of
mammalian DNA replication origins. We demonstrated that deletion of the DUE
eliminated origin activity and DUE-B binding at the c-myc replicator (Figure 6, Ghosh et
al., 2006). The lost origin activity, DUE-B, and Cdc45 binding can be recovered when
the DUEs are replaced with (ATTCT)n≥27 repeats from the ATXN10/SCA10 locus
(Chowdhury et al., 2010; Liu et al., 2007). Furthermore, GAL4DBD DUE-B was tethered
to the GAL4-binding site in place of the ectopic c-myc replicator DUE. However, origin
activity and Cdc45 binding were not restored even in the presence of Orc2, Mcm7 and
GAL4DBD DUE-B binding (Chen et al., 2013).
Taken together, these results demonstrated that a DUE sequence is essential for cmyc replicator activity in addition to DUE binding. However, it remains unclear whether
a DUE sequence alone is sufficient for DNA unwinding and origin activity. To address
this question, the chromatin accessibility of the c-myc DUE sequence in the presence of
protein tethering was evaluated in three different deletion mutants of c-myc replicator, all
of which contain the DUE. DNase I was first used to distinguish the nuclease
accessibility of active from inactive genes (Weintraub and Groudine, 1976). DNase I
cleaves linker DNA unprotected by histones, thus DNase I can be used to map of
nucleosome locations (Simpson 1999). Moreover, DNase I hypersensitivity sites, due to
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their exposed state on the chromatin, are often associated with enhancers, promoters,
replication origins and other features of DNA activity (Wang and Simpson 2001).
In this study, DNase hypersensitivity assays were used to determine chromatin
structure of the ectopic c-myc replicators. β-globin locus was used as an internal control
used for DNase digestions because of its chromatin is resistant to DNase I in a timedependent manner (shown in Figure 11c). Therefore, the increased trend in DNase I
sensitivity of the ectopic c-myc locus in comparison to that of the β-globin locus
indicates an increase in nuclease accessibility, which correlates with a more open
chromatin state.
In this study, GAL4DBD-Cdt1 is the fusion protein used for protein tethering to the
GAL4 binding sites fused to the c-myc ectopic replicators. The exogenous protein
expression levels might affect the DNAse I hypersensitivity in each HeLa/406 derivative
cell line. Another concern is that the expression levels of endogenous Cdt1 were
approximately five times the expression levels of GAL4DBD-Cdt1 across cell lines (Figure
12a, 14a, and 15a). However, the ratio of GAL4DBD-Cdt1 to GAL4 binding sites are
much greater than the ratio of Cdt1 molecules to origins due to GAL4 specificity of the
ectopic c-myc locus. Therefore, GAL4DBD-Cdt1 molecules can bind every available
GAL4 binding site even if some of them enter the pool of endogenous Cdt1 molecules
and bind non-specific origins.
In the presence of GAL4DBD-Cdt1, FRT.myc.5’(930)-GAL4 replicator displayed
increased nuclease sensitivity, while shorter forms of c-myc replicators
(FRT.myc.5’(607)-GAL4 and FRT.myc.5’(228)-GAL4) had unchanged nuclease
sensitivity. These data suggest that additional DNA sequences (up to 930 bp) surrounding
the DUE sequence contribute to the opening of nucleosomal packing, which is required
for protein binding and origin DNA unwinding, the crucial events leading to DNA
replication initiation. In order to determine whether it is the DNA sequence itself or its
length which is important for nuclease sensitivity, ectopic replicator containing
scrambled DNA with the same length as that of FRT.myc.5’(930)-GAL4 in conjunction
to the c-myc DUE can be subjected to DNAse I digestion. Furthermore, since DNA
unwinding is defective in these new c-myc origin deletion mutants in the presence of
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GAL4DBD-Cdt1 expression, we predict that there will be no origin activity at the ectopic
mutant c-myc replicators in the presence of GAL4DBD fusion protein tethering.
GAL4DBD-BRG1 increased the nuclease sensitivity of the c-myc DUE in
HeLa/FRT.myc.5’(930)-GAL4 cells:
BRG1 is a core catalytic subunit of mammalian SWI-SNF chromatin remodeling
complex. BRG1 uses its ATPase activity to break DNA-histone contacts, leading to
repositioning of nucleosomes on the chromatin. Recently, BRG1 has been shown to colocalize with DNA replication factors such as ORC, GINS and proliferating cell nuclear
antigen on chromatin fibers (Cohen et al., 2010). This novel function of BRG1 suggests
that this protein might be involved in origin firings and DNA replication elongation.
Taken together, BRG1 functions as a chromatin remodeler, which is not only important
for gene transcription but also for efficient replication fork progression. However, the
involvement of BRG1 in DNA replication is unclear.
This study attempts to address this question by tethering GAL4DBD-wild-type
BRG1 or GAL4DBD- BRG1K798R catalytic dead mutant to the inactivated ectopic
FRT.myc.5’(930)-GAL4 c-myc replicator. As a result, GAL4DBD- wild-type BRG1expressing HeLa/FRT.myc.5’(930)-GAL4 c-myc cells showed the highest increase in
DNase I sensitivity, whereas GAL4DBD- BRG1K798R-expressing cells show moderate
increase in DNase I sensitivity in comparison to empty-vector treated cells.
Both the wild-type BRG1 and the catalytic dead BRG1K798R mutant have been
shown to stimulate BAF155 and cyclin E complex formation (Shanahan et al., 1999).
BAF155 is a core subunit of the mammalian SWI-SNF complex, which stabilizes the
complex and promotes BRG1 ATPase activity (Phelan et al., 1999; Chen and Archer,
2005). Cyclin E accumulates in late G1 phase, binds to Cdk2, and promotes replication
licensing by phosphorylating Cdc6 protein (Mailand and Diffley, 2005). In a Cdk2independent fashion, cyclin E can also interact with the pre-RC licensing protein Cdt1 on
chromatin and facilitates the loading of the Mcm2-7 helicases (Geng et al., 2007).
Therefore, the presence of either GAL4DBD- wild-type BRG1 or GAL4DBDBRG1K798R might recruit cyclin E to the ectopic c-myc locus, which in turn can facilitate
replication licensing (via Cdc6 and Cdt1), as well as Mcm2-7 loading onto the chromatin.
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However, only GAL4DBD- wild-type BRG1 retains ATPase activity, which can alter the
nucleosome positioning and expose c-myc DNA for nuclease digestion. The data
presented here supported the above predictions. Wild-type BRG1 increased DNase
sensitivity of the ectopic 5’ 930 bp c-myc most significantly, while BRG1K798R mutant
increased DNase sensitivity moderately in comparison to empty vector-transfected cells.
We hypothesize that GAL4DBD-wild-type BRG1 might be able to recruit other
endogenous replication proteins (Cdc45, DUE-B, and ORC) and restore origin activity of
the inactivated c-myc origin. Additional experiments, such as chromatin
immunoprecipitation and quantitative PCR, are necessary to support this hypothesis.
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